REMEDY.HEREMEDY.HEHEL
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank64
3Y CAGR+62.0%
5Y CAGR-16.5%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+62.0%/yr
vs -11.5%/yr prior
5Y CAGR
-16.5%/yr
Recent acceleration
Acceleration
+73.4pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 14.27% | +157.5% |
| 2024 | 5.54% | +107.7% |
| 2023 | -72.14% | -2247.7% |
| 2022 | 3.36% | -89.7% |
| 2021 | 32.66% | -7.2% |
| 2020 | 35.21% | +51.5% |
| 2019 | 23.25% | +325.0% |
| 2018 | 5.47% | -55.3% |
| 2017 | 12.24% | -52.9% |
| 2016 | 26.00% | - |